跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PRZ-AMOXICILLIN - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
PRZ-AMOXICILLIN
Authorized
STANDARD
PRZ-AMOXICILLIN
pharmaris canada inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
bcd08a482948da85
Company
pharmaris canada inc
Type
Standard
Approval Details
Approval Id
bcd08a482948da85
Drug Approval Canada Name
PRZ-AMOXICILLIN
Product Name
PRZ-AMOXICILLIN
Status
Marketed
Status Date
2023-12-22
Original Market Date
2023-12-22
Din
02532042
Drug Class
Human
Dosage Form
Capsule
Route Of Administration
Oral
Schedule
Prescription
Ahfs
08:12.16.08
Atc Original
J01CA04 AMOXICILLIN
Atc Name
j 01 ca 04
Aig Number
0131314001
Company Name
pharmaris canada inc
Company Address
102, 8310 130th Street, Surrey, British Columbia, Canada, V3W 8J9
Active Ingredients
AMOXICILLIN (AMOXICILLIN TRIHYDRATE)
250 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
bcd08a482948da85
Type
Standard
Back to Health Canada Approvals